|
|
|
|
|
|
Vertex Pharmaceuticals Inc (VRTX)
|
|
66.18 -0.74 (-1.11%)
|
4/24/2014 4:00pm
|
|
Open:
|
66.96
|
Pre. Close:
|
66.92
|
|
High:
|
67.49
|
Low:
|
64.05
|
|
Volume:
|
1,204,660
|
Market Cap:
|
15.603B
|
|
|
|
Stock Price Prediction (Update at
5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
68.16 - 69.05
|
69.05 - 69.73
|
|
Low:
|
62.11 - 63.05
|
63.05 - 63.77
|
|
Close:
|
65.04 - 66.62
|
66.62 - 67.85
|
|
|
|
|
|
|
Technical analysis (as of: 2014-04-24 4:38:20 PM)
|
|
Overall:
|
 
|
|
Our rating system posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 83.39  One year: 91.77
|
|
Support:
|
Support1: 59.79 Support2: 49.75
|
|
Resistance:
|
Resistance1:
71.40 Resistance2: 78.57
|
|
Pivot:
|
65.77
|
|
Moving Averages:
|
MA(5): 66.21 MA(20): 67.00
MA(100): 74.80 MA(250): 75.92
|
|
MACD:
|
MACD(12,26):
-2.47 Signal(12,26,9): -3.03
|
|
%K %D:
|
%K(14,3): 55.58 %D(3): 51.79
|
|
RSI:
|
RSI(14): 43.17
|
|
52-Week:
|
High: 89.96
Low: 58.06 Change(%): -16.2
|
|
Average Vol(K):
|
3-Month: 1608
10-Days 1666
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.VRTX has closed below upper band by 45.1%. Bollinger Bands are 18.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Fri, 11 Apr 2014 23:48:45 GMT
Why Biogen Idec Inc., Vertex Pharmaceuticals Incorporated, and Broadcom Corp ...
Tue, 22 Apr 2014 12:22:30 GMT
Vertex Pharmaceuticals (VRTX) Sees Hammer Chart Pattern: Time to Buy?
Tue, 15 Apr 2014 15:11:15 GMT
Analysts View on Biotech Equities -- Research on Organovo Holdings, BioMarin ...
Fri, 18 Apr 2014 10:41:15 GMT
Investor's Watch List - Pharmacyclics, Inc. (PCYC), Vertex Pharmaceuticals ...
Tue, 22 Apr 2014 12:22:30 GMT
Vertex Pharmaceuticals (VRTX) Sees Hammer Chart Pattern: Time to Buy ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
